• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Sanofi CEO: Amid COVID-19 supply push, one fever means 'maybe a half dozen'...

cafead

Administrator
Staff member
  • cafead   Apr 03, 2020 at 12:52: PM
via Sanofi, the maker of a branded hydroxychloroquine drug called Plaquenil, is producing as much as it can to help healthcare systems fighting the pandemic, CEO Paul Hudson told Reuters. But amid the manufacturing push, some employees are having to step aside if they show symptoms.

article source